Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits

Arch Ophthalmol. 1995 Oct;113(10):1324-9. doi: 10.1001/archopht.1995.01100100112040.

Abstract

Purpose: To investigate whether corticosteroid therapy would decrease the inflammation and tissue damage associated with pneumococcal endophthalmitis.

Methods: Albino rabbits were injected intravitreally with 1000 live organisms of Streptococcus pneumoniae and randomized after 24 hours to treatment with intravitreal vancomycin hydrochloride alone (n = 10), combination intravitreal vancomycin and intravitreal dexamethasone (n = 10), or no treatment (n = 10). After 2 weeks, the eyes were examined clinically and enucleated for histopathologic examination.

Results: Eyes treated with vancomycin and dexamethasone had significantly less intraocular inflammation and more preservation of retinal tissue than untreated eyes or eyes treated with vancomycin alone (P < .05, Fisher's exact test). Untreated and vancomycin-treated eyes were indistinguishable on clinical and histologic examination. Marked anterior and posterior segment inflammation with total retinal necrosis was noted in eyes from both groups.

Conclusion: Intravitreal corticosteroid therapy may play an important role in minimizing the inflammation and tissue damage associated with pneumococcal endophthalmitis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Dexamethasone / therapeutic use*
  • Drug Therapy, Combination
  • Endophthalmitis / drug therapy*
  • Endophthalmitis / microbiology
  • Endophthalmitis / pathology
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Bacterial / pathology
  • Pneumococcal Infections / drug therapy*
  • Pneumococcal Infections / pathology
  • Rabbits
  • Random Allocation
  • Streptococcus pneumoniae / drug effects
  • Streptococcus pneumoniae / isolation & purification
  • Vancomycin / therapeutic use*
  • Vitreous Body / microbiology

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Vancomycin
  • Dexamethasone